Vinorelbine tartrate is a semi-synthetic analogue of vincristine and is a odorless, white or white-like powder or crystalline powder.It is soluble in water or ethanol, in acetone or chloroform, and almost insoluble in ether.
This report contains market size and forecasts of Vinorelbine Tartrate in global, including the following market information:
Global Vinorelbine Tartrate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vinorelbine Tartrate Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Vinorelbine Tartrate companies in 2021 (%)
The global Vinorelbine Tartrate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vinorelbine Tartrate include TEVA Pharms, Novartis, Pierre Fabre, Hospira, Hikma, Fresenius Kabi, Hansoh Pharma, Mylan and Dr. Reddy's Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vinorelbine Tartrate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vinorelbine Tartrate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Vinorelbine Tartrate Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Vinorelbine Tartrate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Vinorelbine Tartrate Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Lymphoma
Non-small Cell Lung Cancer
Others
Global Vinorelbine Tartrate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Vinorelbine Tartrate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vinorelbine Tartrate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vinorelbine Tartrate revenues share in global market, 2021 (%)
Key companies Vinorelbine Tartrate sales in global market, 2017-2022 (Estimated), (KG)
Key companies Vinorelbine Tartrate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
TEVA Pharms
Novartis
Pierre Fabre
Hospira
Hikma
Fresenius Kabi
Hansoh Pharma
Mylan
Dr. Reddy's Laboratories
Hangzhou Minsheng Pharmaceutical Group
Nanjing Cuccess Pharmaceutical
Qilu Pharmaceutical
Sinopharm Group
Beijing SL Pharm
Shenzhen Main Luck Pharmaceuticals
Harbin Gloria
Luoxin Group